美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
GANTRISIN	006917	001	NDA	SULFISOXAZOLE DIOLAMINE	INJECTABLE;INJECTION	EQ 400MG BASE/ML	No	No	--	Approved Prior to Jan 1, 1982	ROCHE	Discontinued
GANTRISIN	007757	002	NDA	SULFISOXAZOLE DIOLAMINE	SOLUTION/DROPS;OPHTHALMIC	EQ 4% BASE	No	No	--	Approved Prior to Jan 1, 1982	ROCHE	Discontinued
GANTRISIN	008414	002	NDA	SULFISOXAZOLE DIOLAMINE	OINTMENT;OPHTHALMIC	EQ 4% BASE	No	No	--	Approved Prior to Jan 1, 1982	ROCHE	Discontinued
GANTRISIN	006525	001	NDA	SULFISOXAZOLE	TABLET;ORAL	500MG	No	No	1948/07/29	Approved Prior to Jan 1, 1982	ROCHE	Discontinued
GANTRISIN	009182	002	NDA	SULFISOXAZOLE ACETYL	SYRUP;ORAL	EQ 500MG BASE/5ML	No	No	1953/12/04	Approved Prior to Jan 1, 1982	ROCHE	Discontinued
GANTRISIN PEDIATRIC	009182	004	NDA	SULFISOXAZOLE ACETYL	SUSPENSION;ORAL	EQ 500MG BASE/5ML	No	No	1953/12/04	Approved Prior to Jan 1, 1982	ROCHE	Discontinued
LIPO GANTRISIN	009182	009	NDA	SULFISOXAZOLE ACETYL	EMULSION;ORAL	EQ 1GM BASE/5ML	No	No	1953/12/04	Approved Prior to Jan 1, 1982	ROCHE	Discontinued
AZO GANTRISIN	019358	001	NDA	PHENAZOPYRIDINE HYDROCHLORIDE; SULFISOXAZOLE	TABLET;ORAL	50MG;500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1990/08/31	1990/08/31	ROCHE	Discontinued